Open original FDA record ↗Recall record
- FDA identifier
- Z-3231-2017
- Company in FDA record
- Sorin Group Italia SRL - CRF
- FDA classification date
- Sep 28, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a possibility of overconsumption of certain PLATINIUM Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) following an ElectroStatic Discharge (ESD) during the implant surgery or a Magnetic Resonance Imaging (MRI) scan, and what actions to take.
Source facts
- Action
- LivaNova issued a communication to physicians treating patients implanted with the products in scope in the form of a customer letter beginning July 24, 2017. The letter instructs users to do the following: 1. In order to mitigate the potential risks associated with both triggering events (ESD at implant or MRI scan), LivaNova recommends physicians follow the patients at the periodicity already stated in the implant manual, especially: " Before the patient is discharged and at each subsequent follow-up, it is advisable to check the battery status and the occurrence of system warnings; " It is recommended that a routine follow-up examination be done one month after discharge, and then every three months until the device nears the replacement date.
- Initiated
- 2017-07-24
- Root cause
- Software design
- Terminated
- 2024-01-29
- Distribution
- US Nationwide Distribution
- Recall number
- Z-3231-2017
- Recall status
- Terminated
- CDRH record ID
- 158442
- FDA classified
- 2017-09-28
- Recall event number
- 77983